Skin and Plasma Pharmacokinetics of Povorcitinib After Oral Administration in Healthy Participants: An Open-Label, Multiple-Dose Phase 1 Study

JID Innovations · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles